Molecule Details
InChIKeyGOFBMDJZIXCQGV-UNHORJANSA-N
Compound Name(2S)-N-[(1S,2S,3S,4S)-5-cyclohexyl-1-(cyclohexylmethyl)-2,3-dihydroxy-4-[[(2S)-3-methyl-2-[[methyl(2-pyridylmethyl)carbamoyl]amino]butanoyl]amino]pentyl]-3-methyl-2-[[methyl(2-pyridylmethyl)carbamoyl]amino]butanamide
Canonical SMILESCC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](CC1CCCCC1)[C@H](O)[C@@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL8.07
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
Q9YQ12 protease Human immunodeficiency virus type 1 Pathogen PF00077 8.2 Ki ChEMBL
P04585 gag-pol Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 8.1 Ki BindingDB
Q72874 pol Human immunodeficiency virus type 1 Pathogen PF00077 7.9 Ki ChEMBL